STARD13 and breast carcinoma: To summarize, STARD13, which is triggered by CDH5, HOXD1, and HOXD10 ceRNAs, stimulates Hippo signaling by acting as a ceRNA for upregulating the LATS1/2 and blocks the Rho GTPase/F-actin pathway, inhibiting YAP/TAZ and suppressing EMT and CSC development in breast cancer [82].